Account
Inquiry
Tirzepatide 10mg is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist being developed for type 2 diabetes treatment. The 10mg formulation offers researchers precise dosing capabilities for metabolic studies.
As a dual agonist, tirzepatide 10mg demonstrates significantly better efficacy regarding glucose control and weight reduction compared to selective GLP-1 receptor agonists. The compound has greater affinity for GIP receptors while maintaining potent GLP-1 receptor activity.
Our tirzepatide 10mg is supplied as a white lyophilized powder with purity exceeding 98% by HPLC analysis. The product is strictly for laboratory research use and not intended for human consumption.
Key advantages of our tirzepatide 10mg include:
- Manufactured under strict quality control standards
- Batch-specific Certificate of Analysis provided
- Custom synthesis and packaging options available
- Stable at recommended storage conditions
Researchers utilize tirzepatide 10mg to investigate its unique mechanism of action that mimics natural GIP while providing GLP-1 receptor activation. This dual activity makes it particularly valuable for metabolic disorder research.
For bulk orders of tirzepatide 10mg, we offer competitive pricing and flexible manufacturing options to meet specific research requirements. Our team can provide technical support regarding proper handling, storage, and reconstitution of this peptide compound.
